Selux新一代表型系统用于革兰阴性菌阳性血培养瓶直接药敏试验的多中心评估
该多中心临床试验评估Selux新一代表型系统(含自动化PBC分离器与Selux AST系统)直接从阳性血培养瓶对革兰阴性杆菌进行药敏试验的能力。PBC分离器可在1小时内从阳性血培养制备McFarland等效接种物。研究在4个中心评估了162份新鲜临床阳性血培养样本、307份加种临床样本和87份加种挑战样本,覆盖面板中17种抗菌药物。结果表明,使用BACTEC和BacT/ALERT 3D及BacT/ALERT VIRTUO血培养系统、包括所有主要瓶型,阳性后保存至多16小时,Selux系统的临床性能、重复性和分析性能均一致。
要点
- PBC分离器1小时内从阳性血培养制备McFarland等效接种物,支持直接上机药敏。
- 在4个中心评估162份新鲜临床、307份加种临床和87份加种挑战样本,覆盖17种抗菌药物。
- 阳性后保存至多16小时,临床性能、重复性和分析性能在BACTEC和BacT/ALERT系统及主要瓶型上一致。
核心结论
- Selux PBC分离器与Selux AST系统可直接从阳性血培养瓶快速进行革兰阴性杆菌药敏试验。
- 该联合系统在临床性能、重复性和分析性能上表现一致,可缩短从血培养阳性到获得完整药敏结果的时间。
研究设计与样本
- 多中心临床试验,在4个中心评估Selux新一代表型系统(含自动化PBC分离器和Selux AST系统)直接用于阳性血培养革兰阴性杆菌药敏试验。
- 评估样本包括162份新鲜临床阳性血培养样本、307份加种临床样本和87份加种挑战样本,覆盖面板中17种抗菌药物。
- PBC分离器可在1小时内从阳性血培养制备McFarland等效接种物,便于直接在Selux AST系统上处理。
主要发现
- Selux系统在BACTEC和BacT/ALERT 3D及BacT/ALERT VIRTUO血培养系统上、包括所有主要BACTEC和BacT/ALERT瓶型,阳性后保存至多16小时,临床性能、重复性和分析性能一致。
- PBC分离器与Selux AST系统联合使用,可缩短血培养阳性后获得完整可操作药敏结果的时间。
临床怎么用
- 该联合系统可用于快速脓毒症诊断与管理,帮助在血培养阳性后更早获得完整药敏结果以调整抗菌治疗。
- 适用条件包括:使用BACTEC或BacT/ALERT 3D及BacT/ALERT VIRTUO血培养系统及主要瓶型,阳性后保存至多16小时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Accurate and rapid antimicrobial susceptibility test (AST) results from positive blood cultures are crucial for patient care and combatting antimicrobial resistance. Although recent advancements in rapid direct-from-positive blood culture (PBC) identification platforms have enabled the provision of species-level identification and some resistance marker information within hours after blood culture positivity, AST results required for clinical decision-making often require 48 h after blood culture positivity. This study evaluated the Selux next-generation phenotyping system, including an automated PBC Separator and the Selux AST system in a multicenter clinical trial for their ability to perform AST directly from PBCs for gram-negative bacilli. The PBC separator produces McFarland equivalent inocula from positive blood cultures within 1 h, facilitating direct processing on the Selux AST system. The study evaluated 162 fresh clinical PBC samples, 307 seeded clinical samples, and 87 seeded challenge samples across 4 sites for each of the 17 antimicrobials included in the panel. The results demonstrate that the Selux system's clinical performance, reproducibility, and analytical performances are consistent when using positive blood cultures held for up to 16 h after positivity on the BACTEC and BacT/ALERT 3D and BacT/ALERT VIRTUO blood culture systems, including all major BACTEC and BacT/ALERT blood culture bottle types. These findings suggest that the PBC Separator with the Selux AST system is a valuable addition to the arsenal of tools available for rapid sepsis diagnosis and management.IMPORTANCETechnologies that consistently and substantially shorten the time between blood bottle positivity, organism identification, and complete AST results are crucial for ensuring that antimicrobial therapy can be tailored. The Selux PBC Separator and the Selux AST system perform rapid AST directly from positive blood culture bottles. This substantially shortens the gap between obtaining a positive blood bottle and organism identification and the availability of a fully actionable AST result.
引用
- Streva V, Gajewski J, Pento J, et al. Multi-center evaluation of the Selux next-generation phenotyping system for gram-negative direct-from-positive blood culture antimicrobial susceptibility testing. J Clin Microbiol. 2025. PMID: 40162805. doi:10.1128/jcm.01819-24
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。